| URL | http://www.in-pharmatechnologist.com/Processing/Gl |
| Source | in-pharmatechnologist.com |
| Date Published | 07/21/2014 |
| Author Name | Zachary Brennan |
| Company/Division name | Glenmark |
| Type of work | Manufacturing |
| Reshoring category: | Transplant |
| Year reshoring announced: | 2014 |
| Year reshoring implemented or to be implemented: | 2015 |
| Domestically, the work will be done: | In-house |
| Country(ies) from which reshored: | India |
| State(s) reshored to: | NC |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | Pharmaceuticals |
| What non-domestic negative factors made offshoring less attractive? | Travel cost/time |